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DC COVID-19 STATS THROUGH MAY 17

Obtained from: https://coronavirus.dc.gov/page/coronavirus-data
REGIONAL and LOCAL COVID-19 STATS THROUGH MAY 18 th
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Obtained from: https://www.washingtonpost.com/graphics/local/dc-maryland-virginiacoronavirus-cases/
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DC ICU Bed Capacity
(By %, as of 5/17/20)

DC Ventilator Capacity
(By %, as of 5/17/20)

30.1

48.2

51.8

In-Use

Available

69.9

In-Use

Available

Regional Dashboards and Data Sources:
Washington Post (DC, MD, and VA):
https://www.washingtonpost.com/graphics/local/dc-maryland-virginia-coronavirus-cases/
D.C. Hospital Status Data:
https://coronavirus.dc.gov/page/hospital-status-data
Virginia Hospital and Healthcare Association (VA)
https://www.vhha.com/communications/virginia-hospital-covid-19-data-dashboard/
Maryland Emergency Management Agency (MD):
https://coronavirus.maryland.gov/datasets/md-covid-19-data-dashboard
Johns Hopkins (National):
https://systems.jhu.edu/research/public-health/ncov/
Mass General COVID-19 Symptom Study (National):
https://covid.joinzoe.com/us/data
NPR COVID-19 Daily Testing Rates and Positive Test Ratios (State and National):
https://www.npr.org/sections/health-shots/2020/05/07/851610771/u-s-coronavirustesting-still-falls-short-hows-your-state-doing
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Highlights This Week
● DC has extended the stay-at-home order through June 8.
● Maryland ended its stay-at-home order May 15 at 5:00pm, entering Phase One re-openings.
Individual counties may decide how to proceed:
○ Montgomery County has extended its stay-at-home order until conditions improve,
○ Prince George’s County has extended its stay-at-home order until June 1, and
○ Baltimore Mayor Young extended the stay-at-home order.
● Virginia also lifted stay-at-home order May 15, entering Phase, but allowed Northern
Virginia to continue stay-at-home order for another two weeks.
● In updates in clinical knowledge this week:
○ Small retrospective Italian study shows treatment with high dose IV of the IL-2
receptor blocker anakinra had significantly greater survival and greater vent-free
survival at 21 days in ARDS patients on CPAP
○ Small phase 2 trial from China of triple anti-viral therapy (interferon beta-1b,
lopinavir-ritonavir and ribavirin) was superior to lopinavir-ritonavir in shortening
viral shedding
○ Large NY retrospective study found no mortality difference between patients who
received hydroxychloroquine, azithromycin, or both compared to patients who
received neither and also found higher cardiac death in group given both
○ A Minnesotan health system implemented a remote Covid-19 patient monitoring
platform, providing high patient satisfaction
○ COVID-GRAM: a risk score to predict development of critical illness
○ Further refinement of clinical guidelines continues to be developed:
■ An International Consensus Group has developed guidelines for resuming
elective orthopedic surgery and
■ the Infectious Disease Society of America presents recommendations for
COVID-19 diagnosis and an algorithm for testing
○ Two pediatric studies show that the small number of children with severe infection
can experience a significant burden of disease , needing ICU care, prolonged
hospitalization. While the majority of these children had pre -existing comorbidities, one study showed 16/44 (37%) hospitalized children and 2/9
critically ill children had no underlying comorbidities.
● Surge management: a webinar by HHS Assistant Secretary for Preparedness and Response
and FEMA Health Care Resilience Task Force about their experiences in the hardest hit areas
● Healthcare management and policy: the American College of Physicians gives guidance for
staged resumption of pre -pandemic activities and
● WHO released policy brief on COVID-19 and mental health
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CLINICAL KNOWLEDGE
● Diagnostics
Title: Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources.
Publisher: American Journal of Clinical Pathology
Publication Date: April 18, 2020
URL: https://doi.org/10.1093/ajcp/aqaa064
Key Takeaway: Proof-of-concept study evaluating pooled specimen group RT-PCR testing
to detect SARS-Cov-2, to expand testing capacity in the future. Sample pooling has been
used in other applications for years. When incidence of SARS-CoV-2 infection is 10% or
less, group testing saves reagents and personnel time, increasing testing capability at least
69%.
Title: SARS-CoV-2 Shedding From Asymptomatic Patients: Contribution of Potential
Extrapulmonary Tissue Reservoirs
Publisher: American Journal of Tropical Medicine and Hygiene
Publication Date: April 13, 2020
URL: http://www.ajtmh.org/content/journals/10.4269/ajtmh.20-0279
Key Takeaway: Perspective paper, analyzing human and animal studies - prolonged
COVID positivity even after symptoms resolved, likely explained by extrapulmonary
reservoirs.
Title: Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.
Publisher: IDSA
Publication Date: May 6, 2020
URL: https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics
Key Takeaway: This is the third of 3 IDSA guidelines on COVID, this one deals with
diagnosis providing 15 practical recommendations and an associated algorithm for testing ,
the other two deal with treatment, and infection control.

● Therapeutics
Title: Interleukin-1 blockade with high-dose anakinra in patients with COVID-19,
acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort
study
Publisher: Lancet Rheumatology
Publication Date: May 7, 2020
URL: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30127-2/fulltext
Key Takeaway: Retrospective cohort study from Italy comparing 29 patients with ARDS
on CPAP treated with high dose IV anakinra in addition to standard treatment showed
significantly greater survival at 21 days (90% versus 56%, p=0.009) compared to 16
patients with ARDS on CPAP on standard treatment. Invasive mechanical ventilationfree survival was higher in the anakinra group versus standard treatment group though not
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statistically significant (72% versus 50% , p=0.15). Rates of bacteremia were comparable
between the groups. Discontinuation of anakinra in setting of adverse effects was not
followed by inflammatory relapses. These are interesting findings, but being a small
retrospective cohort study, RCTs are needed to further evaluate this potential threapy.
Title: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in
the treatment of patients admitted to hospital with COVID-19: an open-label,
randomised, phase 2 trial
Publisher: The Lancet
Publication Date: May 8, 2020
URL: https://doi.org/10.1016/S0140-6736(20)31042-4
Key Takeaway: Early triple antiviral therapy (n=86) was safe and superior to lopinavir–
ritonavir alone (n=41) in alleviating symptoms and shortening the duration of viral
shedding (median 7 days versus 12 days from initiation to negative nasopharyngeal swab)
and hospital stay in patients with mild to moderate COVID-19. Adverse events limited to
nausea, diarrhea, fever, and one case of biochemical hepatitis in control group, without
difference between the groups.
Title: Association of Treatment With Hydroxychloroquine or Azithromycin With InHospital Mortality in Patients With COVID-19 in New York State .
Publisher: JAMA. Published online
Publication Date: May 11, 2020
URL: https://jamanetwork.com/journals/jama/fullarticle/2766117
Key Takeaway: Large NY retrospective cohort study found no difference in mortality in
hospitalized COVID-19 patients treated with hydroxychloroquine (n=271), azithromycin
(n=211), or both (n=735) compared to patients who received neither (n=221). Compared with
patients receiving neither, patients receiving both were significantly more likely to
experience cardiac arrest (adjusted OR, 2.13 [95% CI, 1.12-4.05]), though the combination
group was sicker at baseline. No differences in relative likelihood of abnormal EKG findings.
Note: This study, along with other previous studies regarding hydroxychloroquine and
the FDA warning on its use, suggests there is no compelling evidence to continue use of
these drugs for COVID-19 infection except in the context of an approved clinical trial.

Title: Rapid Implementation of a COVID-19 Remote Patient Monitoring Program
Publisher: Journal of the American Medical Information Association
Publication Date: May 11, 2020
URL: https://doi.org/10.1093/jamia/ocaa097
Key Takeaway: 2255 suspected/confirmed COVID-19 patients in a Minnesota health
system used a remote patient monitoring tool (GetWellLoop), allowing two-way
communication between patients and healthcare team (comprised of medical students,
residents, supervising physicians and nurse practitioners), via text messaging platform and
phone calls. Program was staffed 24/7. 74% of 300 enrolled patients surveyed would be
extremely likely to recommend their doctor.
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Title: A strategic approach to COVID-19 vaccine R&D.
Publisher: Science
Publication Date: May 11, 2020
URL: https://science.sciencemag.org/content/early/2020/05/08/science.abc5312
Key Takeaway: An article outlining the challenges with vaccine development, relevant
clinical and immunologic endpoints that need to be targeted, available vaccine platforms and
current status of progress, how the public and private sector need to collaborate to speed up
development, and funding needs to scale up vaccine manufacture.

●

Critical Care
Title: Development and Validation of a Clinical Risk Score to Predict the Occurrence of
Critical Illness in Hospitalized Patients With COVID-19
Publisher: JAMA Internal Medicine
Publication Date: May 12, 2020
URL: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2766086
Key Takeaway: Study in China, using 1590 patients and a validation cohort of 710 patients,
developed and validated a risk score (COVID-GRAM, http://118.126.104.170/) to predict
development of critical illness (ICU admission, mechanical ventilation, or death). The 10
risk score predictors included: chest radiography abnormality, age, hemoptysis, dyspnea,
unconsciousness, number of comorbidities, cancer history, neutrophil-to-lymphocyte ratio,
lactate dehydrogenase, and direct bilirubin. Limitations include need for further validation,
especially in other populations.

● Surgery
Title: Resuming Elective Orthopaedic Surgery During the COVID-19 Pandemic: Guidelines
Developed by the International Consensus Group (ICM)
Publisher: The Journal of Bone and Joint Surgery
Publication Date: May 2020 (In-press Article)
URL: https://journals.lww.com/jbjsjournal/Documents/P-FINAL-Parvizi.pdf
Key Takeaway: Practical guidelines developed by an International Consensus Group,
consisting of 77 expert physicians in Orthopedics, Infectious Disease,
Microbiology/Virology, and Anesthesia, providing recommendations regarding when
elective orthopedic surgery can be resumed and related issues in setting of pandemic.

● Ophthalmology
Title: The Ocular Surface, Coronaviruses and COVID-19
Publisher: Clinical and Experimental Optometry
Publication Date: May 13, 2020
URL: https://onlinelibrary.wiley.com/doi/abs/10.1111/cxo.13088
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Key Takeaway: Literature review analyzing animal and human studies. The evidence
suggests coronaviruses are unlikely to bind to ocular surface cells to initiate infection.
Additionally, hypotheses that the virus could travel from the nasopharynx or through the
conjunctival capillaries to the ocular surface during infection are probably incorrect.

● Gastroenterology
Title: Manifestations and prognosis of gastrointestinal and liver involvement in patients
with COVID-19: a systematic review and meta-analysis
Publisher: The Lancet Gastroenterology and Hepatology
Publication Date: May 12, 2020
URL: https://www.thelancet.com/pdfs/journals/langas/PIIS2468-1253(20)30126-6.pdf
Key Takeaway: Meta-analysis of 35 studies (6686 patients) revealed pooled prevalence of
digestive symptoms (often nausea/vomiting, diarrhea, or loss of appetite) was 15%,
abnormal liver function was 19%. Subgroup analysis showed patients with severe COVID19 had significantly higher rates of gastrointestinal symptoms and liver injury compared with
those with non-severe disease (odds ratio [OR] 1.60 [95% CI 1.09–2.36]; p=0.0020;
I²=44%), OR (2.20 [1.60–3.02]; p<0.00001; I²=36% respectively). Pediatric COVID patients
had a similar prevalence of GI symptoms to those of adults.

● Pediatrics
Title: Characteristics and Outcomes of Children With Coronavirus Disease 2019
(COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Publisher: JAMA Pediatrics
Publication Date: May 11, 2020
URL: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2766037
Key Takeaway: Cross-sectional study of 46 North American PICUs, from March 14-April
3, 2020 found 48 children were admitted to 14 PICUs in the US, 0 in Canada. 40 children
(83%) had at least 1 pre-existing medical condition, 35 (73%) presented with
respiratory symptoms, and 18 (38%) required invasive ventilation. 11 patients (23%) had
2-or more organ failure. By April 10, 2020, mortality rate was 4.2% (2 patients), with 15 still
hospitalized, and 3 on ventilatory support, and 1 receiving ECMO. Children can have severe
infection though far less frequently than adults.
Title: Severe COVID-19 in Children and Young Adults in the Washington, DC
Metropolitan Region
Publisher: Journal of Pediatrics
Publication Date : May 13, 2020
URL: https://www.jpeds.com/article/S0022-3476(20)30581-3/pdf
Key Takeaway: GW-affiliated author. Journal pre-proof of retrospective cohort study of
177 COVID+ children and young adults with clinical symptoms treated at the
Children’s National Hospital. 44/177 required hospitalization of which 9 were critically ill,
median age of critically ill patients compared to non-critically ill patients was significantly
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higher (17.3 vs 3.6 years, p=0.04). Children <1 year old and young adults >15 years old
together accounted for 64% of hospitalizations. Asthma was the most frequent underlying
comorbidity overall, however neurologic disorders, cardiac, hematologic, and oncologic
disorders were significantly more common in hospitalized patients compared to nonhospitalized patients. No underlying health problem was identified in 16/44 (37%)
hospitalized patients and 2/9 critically ill patients. No deaths reported thus far.
Title: Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and
Administration — United States, 2020
Publisher: CDC / MMWR
Publication Date: May 8, 2020
URL: https://www.cdc.gov/mmwr/volumes/69/wr/mm6919e2.htm
Key Takeaway: Observational report examining vaccine tracking data shows declines
vaccination after national emergency declared on March 13, 2020, though less so measlesvaccine doses for children <24 months. It will be important to remind patients to continue
routine vaccinations to prevent vaccine -preventable disease outbreaks in setting of
COVID.

RESOURCES: DECISION-SUPPORT TOOLS, CALCULATORS,
TREATMENT ALGORITHMS
Title: NIOSH PPE Tracker App
Publisher: National Institute of Occupational Safety and Health (NIOSH)
Publication Date: May 4, 2020
URL: https://www.cdc.gov/niosh/ppe/ppeapp.html
Key Takeaway: The NIOSH PPE Tracker App can help healthcare and non-healthcare
systems track their personal protective equipment (PPE) inventory. Facilities can use the app
to calculate their average PPE consumption rate or “burn rate.” The app estimates how many
days a PPE supply will last given current inventory levels and PPE burn rate. It allows entry
by # of individual units or boxes of supply, can calculate for a wide variety of specific PPE
(such as small N95s), and varying number of patients. App will also create downloadable
reports that can be shared via email. Available on iOS and Android.
Note: Although many organizations have released PPE burn rate trackers, this application
may have additional functionality that health administrators may find useful, as outlined
above.

HEALTH WORKFORCE
Title: Rapid Implementation of an Adult COVID-19 Unit in a Children's Hospital
Publisher: Journal of Pediatrics
Publication Date: April 28, 2020
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196893/
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Key Takeaway: Descriptive report of a surge-in-place at a NY children's hospital to meet
the local demands of the COVID-19 pandemic. Instead of re-deploying pediatric providers to
work with internist-led teams throughout a medical center in an unfamiliar setting/team
structure, pediatric physicians and nurses staffed a 40-bed adult COVID-19 treatment
unit within a children's hospital with a dedicated adult hospitalist available for
consultation during the day and senior IM resident check-in call at night.
Note: This is more for informational purposes as Washington, DC Department of Health has
developed surge-capacity at the DC Convention Center.
Title: Containment of COVID-19 cases amongst healthcare workers: the role of
surveillance, early detection and outbreak management
Publisher: Infection Control and Hospital Epidemiology
Publication Date: May 11, 2020
URL: https://doi.org/10.1017/ice.2020.219
Key Takeaway: Descriptive report of surveillance and early detection strategy for 9,322
HCWs at a Singaporean hospital. Monitoring efforts included self-reporting respiratory
symptom, twice daily temperature monitoring, isolation, and temperature/respiratory
symptoms mapping to identify clusters. 14 cases of COVID-19 detected, 2 resulted from
intra-hospital transmission. Swift containment allowed no onward transmission.
Title: Screening of healthcare workers for SARS-CoV-2 highlights the role of
asymptomatic carriage in COVID-19 transmission
Publisher: eLife
Publication Date: May 11, 2020
URL: https://elifesciences.org/articles/58728
Key Takeaway: Large UK hospital screened 1,032 asymptomatic HCWs for SARSCoV-2 from throat and nose self-swab. 17/30 (57%) were truly asymptomatic/paucisymptomatic. 12/30 (40%) had experienced symptoms compatible with COVID-19 infection
>7 days prior to testing, most self-isolating, returning well. Clusters of HCW infection were
discovered on two independent wards.

EPIDEMIOLOGY AND PUBLIC HEALTH
Title: WHO - Policy Brief on Covid-19 and Mental Health
Publisher: World Health Organization
Publication Date: May 13, 2020
URL: https://www.un.org/sites/un2.un.org/files/un_policy_briefcovid_and_mental_health_final.pdf
Key Takeaway: The mental health impact of the Covid-19 pandemic will be profound.
It will have impact on all sectors particularly those with preexisting mental health
diagnoses and also will precipitate an unprecedented need for evaluation and treatment
among those most impacted; newly unemployed, loved ones of those with COVID-19
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disease and related death, and the health workforce . Policy, institutional, community and
clinical programs must be initiated now to address these health concerns.
Title: Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US
Publisher: JAMA Pediatrics
Publication Date: May 13, 2020
URL: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2766115
Key Takeaway: GW affiliated authors. Perspective piece regarding the significant public
health issues facing low-income children that have been uncovered and exacerbated by the
pandemic, many of these issues will have long-standing ramifications as these children grow.

HEALTH DISPARITIES
Title: COVID-19 and Racial/Ethnic Disparities
Publisher: JAMA OnLine
Publication Date: May 11, 2020
URL: https://jamanetwork.com/journals/jama/fullarticle/2766098
Key Takeaway: Editorial highlighting the health disparities revealed by the pandemic, with
possible explanation for these differences. It also discusses opportunities for public health
improvement for these populations and where further study is needed.

MICROBIOLOGY
Title: Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
Publisher: Infection, Genetics, and Evolution (Elsevier)
Publication Date: May 5, 2020
URL: https://www.sciencedirect.com/science/article/pii/S1567134820301829
Key Takeaway: Researchers analyzed 7666 Sars-CoV-2 public genome assemblies with
analysis pointing to a common ancestor near end of 2019, a moderate mutation rate, similar
to other RNA viruses, no distinct phenotypes at this time, and identified 198 filtered
independent recurrent mutations of the virus (homoplasies), with 80% of these producing
non-synonymous changes at the protein level, suggesting areas of ongoing evolutionary
adaptation of the virus. Areas that underwent large number of recurrent mutations (>15
events) include 3 sites in Orf1ab (encoding Nsp6, Nsp11, Nsp13 and one in the Spike
protein, which may indicate areas of convergent evolution. Continuing to monitor genetic
diversity of this virus will be important to target vaccine development toward conserved
genetic regions and to monitor for the development of antiviral drug resistance.
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GOVERNMENT/POLICY UPDATES
Title: Partial Resumption of Economic, Health Care and Other Activities While
Mitigating COVID-19 Risk and Expanding System Capacity A Clinical and Public
Policy Guidance from the American College of Physicians
Publisher: ACP
Publication Date: May 6, 2020
URL:
https://www.acponline.org/acp_policy/policies/acp_guidance_on_resuming_economic_and_s
ocial_activities_2020.pdf
Key Takeaway: Public policy guidance for federal, state, and local authorities for staged
resumption of activities prior to the pandemic.

PUBLIC HEALTH INTERVENTIONS
Title: COVID-19 Contact Tracing Course
Publisher: Johns Hopkins University and Coursera
Publication Date: May 11, 2020
URL: https://www.coursera.org/learn/covid-19-contact-tracing?edocomorp=covid-19contact-tracing
Key Takeaway: This is a 5-hour online beginner contact tracer course teaching about
COVID-19 infection, transmission, utility of contact tracing, how contact tracing is done,
communication skills, ethical considerations and challenges to contact tracing. Available
for free to audit the course, not available for CME. This may be relevant for primary care
providers performing follow-up with COVID+ patients or other providers performing
telephone follow-up after discharge from ED or hospital.

HEALTH CARE FACILITIES
Title: COVID-19: Healthcare System Operations Strategies and Experiences
Publisher: HHS ASPR TRACIE
Publication Date: May 11, 2020
URL: https://files.asprtracie.hhs.gov/documents/covid-19-healthcare-system-operationswebinar-ppt-final.pdf
Key Takeaway: HHS ASPR’s Technical Resources, Assistance Center, and Information
Exchange (TRACIE), in collaboration with the HHS/FEMA Healthcare Resilience Task
Force, hosted a webinar on May 11, 2020 on COVID-19: Healthcare System Operations
Strategies and Experiences. Presenters from a few of the hardest hit hospitals in New
York, Louisiana, and Arizona shared their hospital operations experiences and logistics
(space, staff, and stuff) strategies with the current COVID-19 response.
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EMERGING CONVERSATIONS*
*This section aims to spread emerging ideas from the profess ional rumor mill, in an effort to
keep decision makers apprised of topics that are brewing. While this information may become
part of the COVID pedagogy, it currently represents non-scientific, non-evidence-based
propositions. Accordingly, we do not recommend incorporation into clinical guidelines.
Title: Study to Determine Incidence of Novel Coronavirus Infection in U.S. Children Begins
Publisher: NIAID News Release
Publication Date: May 4, 2020
URL: https://www.niaid.nih.gov/news-events/study-determine-incidence-novel-coronavirusinfection-us-children-begins
Key Takeaway: News release on HEROS study to prospectively follow 6000 people from
2000 US families already enrolled in NIH research to look at SARS-CoV-2 infection rates,
and subsequent symptom development. An aim of the study is to determine if persons with
allergic conditions may be less susceptible to SARS-CoV-2 due to less ACE2 in upper and
lower airway cells, based on preliminary evidence.

GWU RESEARCH OPPORTUNITY
Special Intramural Funding Opportunity: COVID-19 Research Fund:
The Office of the Vice President for Research, the Milken Institute School of Public Health and
the School of Medicine and Health Sciences announces a new special funding opportunity, the
COVID-19 Research Fund. Funds will be rewarded to projects that generate relevant data,
engage investigators from multiple different fields, address telehealth, propose repurposing of
existing drugs, and emphasize GW’s core services. Open to all full time faculty.
More information can be found through this link: https://research.gwu.edu/covid-19-researchfund
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